THE BENZAZEPINE SCH-23390 INCREASES PLASMA-LEVELS OF CORTISOL IN THE CONSCIOUS DOG

被引：3

作者：

GOINY, M ^{[1
]}

HERRERAMARSCHITZ, M ^{[1
]}

UVNASMOBERG, K ^{[1
]}

CEKAN, S ^{[1
]}

UNGERSTEDT, U ^{[1
]}

机构：

[1] KAROLINSKA HOSP,REPROD ENDOCRINOL RES UNIT,S-10401 STOCKHOLM,SWEDEN

来源：

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1986年 / 332卷 / 01期

关键词：

D O I：

10.1007/BF00633207

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：111 / 112

页数：2

共 13 条

[1]

BHATTACG.AN, 1969, J PHARMACOL EXP THER, V165, P108

[2]

BUCKINGHAM JC, 1980, PHARMACOL REV, V31, P253

[3]

DEWIED D, 1967, PHARMACOL REV, V19, P251

[4]

GIRAUD P, 1980, EUR J PHARMACOL, V62, P215, DOI 10.1016/0014-2999(80)90279-4

[5] 5HT-RECEPTOR ANTAGONIST PROPERTIES OF SCH 23390 IN VASCULAR SMOOTH-MUSCLE AND BRAIN [J].

HICKS, PE ;

SCHOEMAKER, H ;

LANGER, SZ .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 105 (3-4) :339-342

[6] SCH-23390 - THE 1ST SELECTIVE DOPAMINE D-1 ANTAGONIST [J].

HYTTEL, J .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 91 (01) :153-154

[7]

HYTTEL J, 1985, DYSKINESIA RES TRE S, V2, P9

[8]

IORIO LC, 1983, J PHARMACOL EXP THER, V226, P462

[9] 5-HT2 RECEPTOR BLOCKADE TO STUDY SEROTONIN-INDUCED PATHOLOGY [J].

JANSSEN, PAJ .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1983, 4 (05) :198-206

[10]

PEROUTKA SJ, 1980, AM J PSYCHIAT, V137, P1518

← 1 2 →